

 
 
Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
 
Most Trending
HRMY
Harmony Biosciences
$28.90
 Login to see Harmony Biosciences  (HRMY)  Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
  Login to see Harmony Biosciences  (HRMY)  Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid Strengths

Upgraded on attractively valued

Earnings are forecast to grow
Chart
$26.76 (+8.00%)
$34.67 (-16.64%)
$35.43 (-18.43%)
$35.08 (-17.62%)
HRMY has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

 
HRMY overall standing based on key factors, offering insights into analysts perspectives and market expectations.
 Hover over the category for more information
Hover over the category for more information
Earnings
Earnings

Reported a strong earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

HRMY Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
 
 
HRMY Street view is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
 Login to display
  Login to displayHRMY Earnings
The TTM reflects 12-month period, providing review of HRMY financial performance.
The company financial health has moderately improved over the past year
Financial Score
What is HRMY current stock price?
What are HRMY stock strengths?
What risks are associated with HRMY stock?
When is HRMY next earnings report?
What is HRMY market cap and volume?
What is HRMY's current Stock IQ?
Should I buy HRMY stock right now?
Is HRMY a Strong Buy right now?
What does a 'Strong Buy' rating mean for HRMY?
What does a 'Strong Sell' rating mean for HRMY?
What factors influence HRMY's Stock IQ?
 
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
HRMY
Harmony Biosciences
Current Price
$28.90
Stock Insights
Strengths

Upgraded on attractively valued

Earnings are forecast to grow
 Login to unlock Harmony Biosciences  (HRMY) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
  Login to unlock Harmony Biosciences  (HRMY) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid  
Chart
$26.76 (+8.00%)
$34.67 (-16.64%)
$35.43 (-18.43%)
$35.08 (-17.62%)
HRMY Analysts Opinion
 
HRMY Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
 Hover over the category for more information
Hover over the category for more information
Earnings
Earnings

Reported a strong earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

HRMY Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
 
 
HRMY Street view is extremely bullish and have positive views on the near-term outlook
HRMY has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

Average key support and resistance price levels.
 Login to display
  Login to displayHRMY Earnings
The TTM data reflects the most recent 12-month period, providing overview of HRMY financial performance.
HRMY Financial Health
The company financial health has moderately improved over the past year
Financial Score
HRMY Latest Analysis
Harmony Biosciences Holdings Inc. (HRMY) Earnings Expected to Grow: Should You Buy?. Harmony Biosciences (HRMY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Tue Oct 28, 2025
Harmony Biosciences Rises 10.6% On Strong Q3 WAKIX Results And Upgraded Guidance . (RTTNews) - Harmony Biosciences Holdings Inc. (HRMY) rose 10.58% to $29.05 gaining $2.78 after the company pre-announced net product revenue of approximately $239 million for the third quarter of 2025 from its WAKIX franchise representing around 29% year-over-year growth.
Thu Oct 23, 2025
Harmony Biosciences reports Q3 revenue of $239M raises FY25 revenue guidance.
Thu Oct 23, 2025
UBS Maintains Harmony Biosciences Holdings (HRMY) Buy Recommendation. Fintel reports that on October 15 2025 UBS maintained coverage of Harmony Biosciences Holdings (NasdaqGM:HRMY) with a Buy recommendation. Analyst Price Forecast Suggests 70.53% Upside
Thu Oct 16, 2025
 
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
HRMY Stock trends
HRMY Stock performance
HRMY Stock analysis
HRMY investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS"). 
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.